For example, certain antimicrobial agents (i.e., clarithromycin, levofloxacin, sulfamethoxazole-trimethoprim, metronidazole, and ciprofloxacin) can interact with sulfonylureas to increase the risk of hypoglycemia [29, 30]
However, it has also been shown to be highly effective in promoting weight loss for individuals who struggle with obesity or other weight-related conditions
Janoshik COA verified
doi:10.1001/jamaoncol.2025.2681 Wolff Sagy Y, et al
If the regulatory review proceeds smoothly, industry analysts project official FDA approval and commercial availability by late 2027 or early 2028
The molecules, indications, and practical requirements differ enough that conflating them does a disservice to patients who need clear guidance